cp wire

CP Wire Articles

Novo Nordisk Acquires Ground Breaking Glucose Company Ziylo for up to $800M+
  • The acquisition supports Novo Nordisk's goal to develop glucose responsive insulins
  • ... read more
Fri, 08/17/18 - 09:52 am
CP Staff
OHSU to Conduct Clinical Trials with Artificial Pancreas Using Xeris' Liquid Glucagon
  • Current dry-powder glucagon formulations must be used immediately because they begin to degrade after reconstitution
  • Xeris’ ready-to-use liquid glucagon is room-temperature stable... read more
Fri, 08/17/18 - 09:24 am
CP Staff
BioNTech to Receive $120 Million Upfront Payment from Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza
  • BioNTech will receive $120 million in upfront, equity and near-term research payments
  • Company is elligible for $305 million in additional payments
  • BioNTech has additional... read more
Thu, 08/16/18 - 10:11 am
CP Staff
Teva and Regeneron's Fasinumab Meets Primary and Secondary Endpoints in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip

Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced on 8/16/18 positive topline results from a Phase 3, randomized, double-blind,... read more

Thu, 08/16/18 - 09:58 am
CP Staff
Dose Escalation Cohort to be Initiated in Adaptimmune's MAGE-A4 SPEAR T-Cell Basket Study

Adaptimmune Therapeutics plc (Nasdaq:ADAP) announced on 8/14/18 a favorable review of safety data from the second dose cohort of patients who received one billion transduced SPEAR T‑cells... read more

Wed, 08/15/18 - 09:50 am
CP Staff
CEL-SCI Gets Independent Recommendation to Continue PH III Head and Neck Cancer Trial

CEL-SCI Corporation (NYSE American: CVM) announced on 8/15/18 that the Independent Data Monitoring Committee (IDMC) for the Company's pivotal Phase 3 head and neck cancer study of its... read more

Wed, 08/15/18 - 09:27 am
CP Staff
Onspira Therapeutics' OSP-101 Receives Orphan Drug Designation for Bronchiolitis Obliterans
  • No currently approved drugs for Bronchiolitis Obliterans
  • OSP-101 is the first and only inhaled interleukin-1 receptor antagonist
  • Nearly 80 percent of lung transplant... read more
Tue, 08/14/18 - 10:31 am
CP Staff
Ironshore Pharmaceuticals Books $143 Million with Private Placement

Ironshore Pharmaceuticals & Development, Inc. (“Ironshore”), a wholly owned subsidiary of Highland Therapeutics Inc., announced on 8/14/18 that it has entered into agreements with purchasers... read more

Tue, 08/14/18 - 10:13 am
CP Staff
iSchemaView's RAPID Technology Now Installed in More Than 500 Stroke Centers
  • 575 stroke centers committed to using the RAPID platform
  • Adoption is up 48% since April
  • Technology recently used in two landmark stroke trials


IschemaView... read more

Tue, 08/14/18 - 09:51 am
CP Staff
Pre-clinical Data Supports Synlogic's Synthetic Biotic as a Potential Treatment for Phenylketonuria



Synlogic, Inc., (Nasdaq: SYBX) announced on 8/13/18 the publication of data from preclinical studies of SYNB1618, the Company’s Synthetic Biotic development program targeting PKU, in... read more

Mon, 08/13/18 - 11:54 pm
CP Staff
Sarepta Invests $30 Million in Gene Therapy Company

UF Innovate | Sid Martin Biotech, a biotechnology incubator at the University of Florida, announced on 8/13/18 that resident company Lacerta... read more

Mon, 08/13/18 - 09:44 am
CP Staff
Accelerator Life Science Partners Launch Startup With $31 Million Series A
  • Parters include:Eli Lilly, Pfizer Ventures, JNJ Ventures, and AbbVie Ventures
  • Company will focus on slowing or stopping neuronal loss in certain disease states


... read more

Mon, 08/13/18 - 09:24 am
CP Staff
Microbiome Report for the Week Ending 8-4-18


Azitra Awarded NIH SBIR Grant to Develop Microbiome – based Therapeutic for Netherton Syndrome

... read more

Fri, 08/10/18 - 09:16 am
CP Staff
FDA Grants Orphan Drug Designation to Neuralstem's Treatment for Angelman Syndrome

Neuralstem, Inc. (Nasdaq:CUR) announced on 8/9/18 that the U.S. Food and Drug Administration has granted orphan drug designation to NSI-189 for the... read more

Thu, 08/9/18 - 09:46 am
CP Staff
Third Rock and Takeda Fund $140 Million Startup to Create Regenerative Therapies for Liver Diseases

Ambys Medicines launched on 8/8/18 with a $60 million Series A financing funded by Third Rock Ventures and Takeda. As part of the launch, Ambys also announced today a strategic partnership with... read more

Wed, 08/8/18 - 09:17 am
CP Staff
Clovis Starts Ph III Trial with Combination of Rubraca and Opdivo in Advanced Ovarian Cancer



Clovis Oncology, Inc. (NASDAQ: CLVS) announced on 8/8/18 the randomization of the first patient in the Phase 3 ATHENA trial evaluating the combination of Clovis’ Rubraca (rucaparib), a... read more

Wed, 08/8/18 - 09:01 am
CP Staff
How Companies Protect Intellectual Property Involving Live Microbes - Interview With a Patent Attorney



With so many companies developing products related to the microbiome that include live microbes, we were curious about how companies are protecting their intellectual property. Since some... read more

Tue, 08/7/18 - 10:59 am
CP Staff
SBIR Awards $2.3 Million Grant to Agilvax to Advance Immunotherapy for Triple Negative Breast Cancer

Agilvax, Inc. announced on 8/7/18 the receipt of a Fast Track Small Business Innovation Research (SBIR) grant from the National Cancer Institute (NCI). The grant will provide up to $2.3 million in... read more

Tue, 08/7/18 - 09:59 am
CP Staff
China Approves Gilead's Genvoya for HIV-1 Infection
  • Genvoya is the first TAF-based single tablet regimen for the treatment of HIV to be approved in China
  • There were approximately 140,000 people newly diagnosed with HIV in China as of... read more
Mon, 08/6/18 - 09:35 am
admin
Harpoon Therapeutics Begins Trial of Novel Immuno-Oncololgy Drug in Patients with Metastatic Castration-Resistant Prostate Cancer
  • Clinical data expected in 2019
  • HPN424 is designed as an ‘off-the-shelf’ T cell therapy
  • HPN424 serum half-life of 80 hours supporting once-weekly administration
... read more
Mon, 08/6/18 - 09:20 am
admin

Pages

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.